LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1,193 Cr | ₹1,159 Cr | ₹1,179 Cr | ₹928 Cr | ₹693 Cr |
What is the latest Total Non-Current Liabilities ratio of LAURUS LABS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹1,193 Cr |
Mar2024 | ₹1,159 Cr |
Mar2023 | ₹1,179 Cr |
Mar2022 | ₹928 Cr |
Mar2021 | ₹693 Cr |
How is Total Non-Current Liabilities of LAURUS LABS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹1,193 Cr | 2.95 | |
Mar2024 | ₹1,159 Cr | -1.72 | |
Mar2023 | ₹1,179 Cr | 27.10 | |
Mar2022 | ₹928 Cr | 33.94 | |
Mar2021 | ₹693 Cr | - |
Compare Total Non-Current Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹44,608.7 Cr | 0.3% | 28% | 76.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 0.3% |
28% |
76.8% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses